Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines

Cancer Detection and Prevention

Volumn 31, Issue 2, 2007, Pages 110-118

  Ullmannova, Veronika ^a   Popescu, Nicholas C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Breast cancer; Cell cycle; Cell growth inhibition; Colon cancer; Deleted in liver cancer 1 gene (DLC 1 gene); DNA methylation; Flavone; Proto oncogenes; Tumor suppressor genes

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; FLAVONE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL TRANSFER; COLON CARCINOMA; CONTROLLED STUDY; DELETED IN LIVER CANCER 1 GENE; DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GADD GENE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IGFBP3 GENE; LIVER CANCER; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; STMN1 GENE; TUMOR SUPPRESSOR GENE; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA METHYLATION; FEMALE; FLAVONES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOBLOTTING; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 34247560163     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.02.005     Document Type: Article

References (52)

1. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58 (1998) 2196-2199
2. Goodison S., Yuan J., Sloan D., Kim R., Li C., Popescu N.C., et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 65 (2005) 6042-6053
3. Seng T.J., Low J.S., Li H., Cui Y., Goh H.K., Wong M.L., et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26 (2006) 934-944
4. Syed V., Mukherjee K., Lyons-Weiler J., Lau K.M., Mashima T., Tsuruo T., et al. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24 (2005) 1774-1787
5. Wong C.M., Yam J.W., Ching Y.P., Yau T.O., Leung T.H., Jin D.Y., et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 65 (2005) 8861-8868
6. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., et al. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22 (2003) 445-450
7. Yuan B.Z., Jefferson A.M., Baldwin K.T., Thorgeirsson S.S., Popescu N.C., and Reynolds S.H. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23 (2004) 1405-1411
8. Zhou X., Thorgeirsson S.S., and Popescu N.C. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23 (2004) 1308-1313
9. Bren-Mattison Y., Van Putten V., Chan D., Winn R., Geraci M.W., and Nemenoff R.A. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small cell lung cancer cells (NSCLC). Oncogene 24 (2005) 1412-1422
10. Zirn B., Samans B., Spangenberg C., Graf N., Eilers M., and Gessler M. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 24 (2005) 5246-5251
11. Folgueira M.A., Carraro D.M., Brentani H., Patrao D.F., Barbosa E.M., Netto M.M., et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 11 (2005) 7434-7443
12. Herzog A., Kindermann B., Doring F., Daniel H., and Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics 4 (2004) 2455-2464
13. Yuan B.Z., Durkin M.E., and Popescu N.C. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet 140 (2003) 113-117
14. Tang K., Oeth P., Kammerer S., Denissenko M.F., Ekblom J., Jurinke C., et al. Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry. J Proteome Res 3 (2004) 218-227
15. van den Boom D., Beaulieu M., Oeth P., Roth R., Honisch C., Nelson M.R., et al. MALDI-TOF MS: a platform technology for genetic discovery. Int J Mass Spectrom 238 (2004) 173-188
16. Chen Y.C., Shen S.C., Chow J.M., Ko C.H., and Tseng S.W. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 25 (2004) 661-670
17. Guan M., Zhou X., Soulitzis N., Spandidos D.A., and Popescu N.C. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res 12 (2006) 1412-1419
18. Ullmannova V., Stockbauer P., Hradcova M., Soucek J., and Haskovec C. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk Res 27 (2003) 1115-1123
19. Mattarucchi E., Marsoni M., Passi A., Lo C.F., Pasquali F., and Porta G. Establishment and study of different real-time polymerase chain reaction assays for the quantification of cells with deletions of chromosome 7. J Mol Diagn 8 (2006) 218-224
20. Nagaraja G.M., and Kandpal R.P. Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins. Biochem Biophys Res Commun 313 (2004) 654-665
21. Takimoto R., and El-Deiry W.S. DNA replication blockade impairs p53-transactivation. Proc Natl Acad Sci USA 98 (2001) 781-783
22. Shu X.O., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10 (2001) 483-488
23. Wu A.H., Wan P., Hankin J., Tseng C.C., Yu M.C., and Pike M.C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 (2002) 1491-1496
24. Le Bail J.C., Aubourg L., and Habrioux G. Effects of pinostrobin on estrogen metabolism and estrogen receptor transactivation. Cancer Lett 156 (2000) 37-44
25. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., and Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30A (1994) 1675-1682
26. Wang C., and Kurzer M.S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28 (1997) 236-247
27. Zava D.T., and Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27 (1997) 31-40
28. Dave B., Eason R.R., Till S.R., Geng Y., Velarde M.C., Badger T.M., et al. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26 (2005) 1793-1803
29. Vissac-Sabatier C., Coxam V., Dechelotte P., Picherit C., Horcajada M.N., Davicco M.J., et al. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res 63 (2003) 6607-6612
30. Singletary K., and Ellington A. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells. Anticancer Res 26 (2006) 1039-1048
31. Vissac-Sabatier C., Bignon Y.J., and Bernard-Gallon D.J. Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr Cancer 45 (2003) 247-255
32. Leung T.H., Ching Y.P., Yam J.W., Wong C.M., Yau T.O., Jin D.Y., et al. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci USA 102 (2005) 15207-15212
33. 2/M arrest in keratinocytes. Carcinogenesis 17 (1996) 2367-2375
34. 2-M. Cancer Res 53 (1993) 1328-1331
35. 2-M arrest in rat neuronal cells. Biochem Biophys Res Commun 204 (1994) 578-584
36. 2/M arrest and induction of apoptosis. Drug Metab Dispos 34 (2006) 296-304
37. Scott D.W., Mutamba S., Hopkins R.G., and Loo G. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate. J Cell Physiol 202 (2005) 295-303
38. Ludwig R.L., Bates S., and Vousden K.H. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 16 (1996) 4952-4960
39. Bouras T., Southey M.C., Chang A.C., Reddel R.R., Willhite D., Glynne R., et al. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62 (2002) 1289-1295
40. Gagliardi A.D., Kuo E.Y., Raulic S., Wagner G.F., and DiMattia G.E. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 288 (2005) E92-E105
41. Rocha R.L., Hilsenbeck S.G., Jackson J.G., Lee A.V., Figueroa J.A., and Yee D. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88 (1996) 601-606
42. Alli E., Bash-Babula J., Yang J.M., and Hait W.N. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62 (2002) 6864-6869
43. Alli E., Yang J.M., and Hait W.N. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26 (2006) 1003-1012
44. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
45. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
46. Takagaki N., Sowa Y., Oki T., Nakanishi R., Yogosawa S., and Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol 26 (2005) 185-189
47. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63 (2003) 7563-7570
48. Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., and Yang C.S. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11 (2005) 7033-7041
49. Shi H., Guo J., Duff D.J., Rahmatpanah F., Chitima-Matsiga R., Al-Kuhlani M., et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 28 (2007) 60-70
50. Hillman G.G., Forman J.D., Kucuk O., Yudelev M., Maughan R.L., Rubio J., et al. Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res 7 (2001) 382-390
51. Li Y., Ellis K.L., Ali S., El-Rayes B.F., Nedeljkovic-Kurepa A., Kucuk O., et al. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas 28 (2004) e90-e95
52. Sarkar F.H., and Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66 (2006) 3347-3350